Skip to main content
. 2019 Jul 15;59(2):292–302. doi: 10.1093/rheumatology/kez265

Fig. 1.

Fig. 1

Incidence rates of selected AEs by 6-month interval

AE: adverse event; csDMARD: conventional synthetic DMARD; MACE: major adverse cardiovascular event; PY: patient-years.